This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Flowers Foods' (FLO) Prudent Acquisitions & Pricing Aid Sales
by Zacks Equity Research
Flowers Foods (FLO) is focusing on acquisitions to strengthen its product portfolio and expand in untapped markets. The company is benefiting from its pricing efforts for a while now.
Hershey (HSY) Looks Promising on Pricing & Prudent Buyouts
by Zacks Equity Research
Hershey's (HSY) solid pricing initiatives have been yielding results for a while. The company has strategically increased its presence and expanded its portfolio through acquisitions.
TreeHouse Foods (THS) Hurt by Cost Inflation, Pricing Aids
by Zacks Equity Research
TreeHouse Foods (THS) is battling commodity, labor and freight cost inflation. However, the company has been on track with pricing efforts, which are expected to boost net sales in 2022.
B&G Foods (BGS) Stock Declines 13% YTD on Cost Inflation
by Vrishali Bagree
B&G Foods (BGS) is encountering escalated cost concerns. Management expects to keep seeing significant cost inflation for inputs, such as ingredients, packaging and transportation.
Kraft Heinz (KHC) Poised on Transformation & Pricing Efforts
by Zacks Equity Research
Kraft Heinz (KHC) is benefiting from efforts to transform its business to unleash its potential. Also, solid pricing actions bode well amid an inflationary environment.
General Mills (GIS) Beats on Q3 Earnings & Sales, Ups View
by Zacks Equity Research
General Mills (GIS) registers higher earnings in third-quarter fiscal 2022. Management raises fiscal 2022 guidance.
Newell's (NWL) NUK Launches Sustainable Baby Collection
by Zacks Equity Research
Newell's (NWL) NUK brand launches its first sustainable babywear products made of recycled fiber. The product line includes seven products available in stores and online at Target.
Coty (COTY) Well Poised on Core Priorities & Prudent Alliances
by Zacks Equity Research
Coty (COTY) has been benefiting from its six strategic pillars and gains from partnerships. Although management expects cost inflation in fiscal 2022, its saving efforts are noteworthy.
Sysco (SYY) Looks Troubled Due to Escalated Cost Concerns
by Zacks Equity Research
Sysco (SYY) has been encountering product cost inflation in the U.S. Foodservice unit. The company revised its back-half view due to the hurdles caused by Omicron and a tough labor scenario.
TreeHouse Foods (THS) Open to Selling Portions of its Business
by Zacks Equity Research
TreeHouse Foods (THS) will not sell the entire company, but is open to divesting portions of its business, like the Meal Preparation business.
Nu Skin's (NUS) Effective Growth Efforts & Product Launches Aid
by Zacks Equity Research
Nu Skin (NUS) is optimistic about its Nu Vision 2025 strategy to become the world's leading integrated beauty and wellness company, driven by a dynamic affiliate opportunity platform.
Down 11.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Flowers Foods (FLO)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Flowers Foods (FLO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Here's How Colgate (CL) Stock is Poised Amid Cost Headwinds
by Zacks Equity Research
Despite raw material cost inflation, Colgate's (CL) robust innovation and expansion plans are likely to drive growth in the long term.
Tyson Foods (TSN) Up More Than 15% in Six Months: Here's Why
by Zacks Equity Research
Tyson Foods (TSN) is benefiting from robust growth in the retail core business. It is focused on higher protein production to cater to the rising demand.
Philip Morris (PM) to Reduce Operations in Russian Federation
by Zacks Equity Research
Philip Morris (PM) suspends planned investments in the Russian Federation. Additionally, the company initiates plans to lower manufacturing operations in Russia.
United Natural Foods (UNFI) Q2 Earnings Top Estimates, Sales Up
by Zacks Equity Research
United Natural Foods' (UNFI) second-quarter fiscal 2022 performance reflects higher net sales and earnings. Management raises fiscal 2022 net sales view.
Campbell (CPB) Q2 Earnings Top Estimates, Sales Decline Y/Y
by Zacks Equity Research
Campbell Soup's (CPB) second-quarter fiscal 2022 results reflect supply-chain disruptions and inflation across the industry, partly made up by positive pricing and sales allowances.
Church & Dwight (CHD) Gains on Demand, Pricing Amid Cost Woes
by Zacks Equity Research
Church & Dwight (CHD) has been gaining on solid demand trends, with its brands getting a boost from innovation and buyouts. Also, the company's pricing has been aiding amid cost inflation.
Hershey (HSY) Rises More Than 15% in 6 Months: Here's Why
by Zacks Equity Research
Hershey (HSY) makes several strategic acquisitions to enhance its brand portfolio. The company's solid pricing initiatives are also yielding.
B&G Foods (BGS) Q4 Earnings Lag Estimates: Input Costs High
by Zacks Equity Research
B&G Foods' (BGS) fourth-quarter fiscal 2021 results reflect year-over-year growth in earnings and sales. Gains from Crisco's buyout and high demand aid the company amid high input costs and supply-chain challenges.
The J.M. Smucker (SJM) Q3 Earnings Beat Estimates, Sales Down
by Zacks Equity Research
The J.M. Smucker's (SJM) third-quarter fiscal 2022 results reflect lower earnings and sales amid rising costs environment and supply chain disruptions.
Kimberly-Clark (KMB) Boosts Portfolio With Thinx Investment
by Zacks Equity Research
Kimberly-Clark (KMB) acquires a majority stake in Thinx to create a portfolio of period and light bladder leakage solutions.
Is Flowers Foods (FLO) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Flowers Foods (FLO) and Hershey (HSY) have performed compared to their sector so far this year.
Kraft Heinz (KHC) Raises View on Effective Transformation
by Zacks Equity Research
Kraft Heinz (KHC) raises long-term growth targets on an improved portfolio and Operating Model combined with the promising AGILE@SCALE strategy.
Medifast (MED) Q4 Earnings Beat, Strength in OPTAVIA Key Driver
by Zacks Equity Research
Medifast's (MED) fourth-quarter 2021 results reflect stellar earnings and revenues, courtesy of continued strength in OPTAVIA. Sales and earnings view for 2022 reflect year-over-year growth.